Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02626000 |
|---|---|
| Brief Title: | Talimogene Laherparepvec With Pembrolizumab for Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY232 / KEYNOTE-137) (MASTERKEY232) |
| First Submitted : | November 18, 2015 |
| First Submitted that Met QC Criteria : | December 7, 2015 |
| First Posted : | December 10, 2015 (Estimate) |
| Results First Submitted : | October 19, 2018 |
| Results First Submitted that Met QC Criteria : | March 13, 2019 |
| Results First Posted : | June 10, 2019 |
| Last Update Submitted that Met QC Criteria : | August 13, 2021 |
| Last Update Posted : | September 8, 2021 |